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Abstract 
 Magnetic nanoparticles (MNPs) are of immense interest for diagnostic and therapeutic 
applications in medicine. Design and development of new iron oxide-based MNPs for such 
applications is of rather limited breadth without reliable and sensitive methods to determine their 
levels in body tissues. Commonly used methods, such as ICP, are quite problematic, due to the 
inability to decipher the origin of the detected iron, i.e. whether it originates from the MNPs or 
endogenous from tissues and bodily fluids. One of the approaches to overcome this problem and 
to increase reliability of tracing MNPs is to partially substitute iron ions in the MNPs with Er. 
Here, we report on the development of citric acid coated (Fe,Er)3O4 nanoparticles and 
characterization of their physico-chemical and biological properties by utilization of various 
complementary approaches. The synthesized MNPs had a narrow (6-7 nm) size distribution, as 
consistently seen in atomic pair distribution function, transmission electron microscopy, and DC 
magnetization measurements. The particles were found to be superparamagnetic, with a 
pronounced maximum in measured zero-field cooled magnetization at around 90 K. Reduction in 
saturation magnetization due to incorporation of 1.7% Er
3+ 
into the Fe3O4 matrix was clearly 
observed. From the biological standpoint, citric acid coated (Fe,Er)3O4 NPs were found to induce 
low toxicity both in human cell fibroblasts and in zebrafish (Danio rerio) embryos. 
Biodistribution pattern of the MNPs after intravenous administration in healthy Wistar rats was 
followed by the radiotracer method, revealing that 
90
Y-labeled MNPs were predominantly found 
in liver (75.33% ID), followed by lungs (16.70% ID) and spleen (2.83% ID). Quantitative 
agreement with these observations was obtained by ICP-MS elemental analysis using Er as the 
detected tracer. Based on the favorable physical, chemical and biological characteristics, citric 
acid coated (Fe,Er)3O4 MNPs could be further considered for the potential application as a 
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diagnostic and/or therapeutic agent. This work also demonstrates that combined application of 
these techniques is a promising tool for studies of pharmacokinetics of the new MNPs in 
complex biological systems. 
 
KEYWORDS: Magnetic nanoparticle, Biodistribution, Embryotoxicity, Radiolabeling, MNP 
1. Introduction 
Magnetic nanoparticles (MNPs) are currently being intensively investigated due to their wide 
range of possible applications in different branches of technology [1].The field of medicine 
offers numerous opportunities for improvement of diagnostics and therapy using MNPs. The 
most promising medical applications of MNPs are in magnetic resonance imaging, drug delivery 
and as heating agents in magnetic hyperthermia [2-6]. In order to be used for medical 
applications, MNPs should be biocompatible, with suitable magnetic properties, narrow size 
distribution, as well as having chemical stability. 
The only FDA approved magnetic material that can be used in human therapy so far is 
magnetite (Fe3O4) [7]. Nevertheless, applications of different methodologies for MNP detection 
in vivo [8] are scarce. One of the greatest challenges to that effect is reliably quantifying the 
biodistribution of exogenous iron oxide based nanoparticles in the presence of the background 
signal originating from very abundant endogenous iron ions. Usually, the distribution and 
accumulation of MNPs in different organs is evaluated using a combination of several 
techniques, including magnetic resonance imaging, X-ray fluorescence and X-ray absorption [9]. 
Elemental analysis based on inductively coupled plasma optical emission (ICP-OES) and mass 
spectrometry (ICP-MS) is a frequently used method for studying both pharmacokinetics and 
biodistribution [10]. Although ICP-MS has a rather high sensitivity for detecting iron, it is not 
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reliable as a MNP-specific tracer, since iron is found in abundance in all biological fluids and 
tissues in the forms of hemoglobin, ferritin, and myoglobin. The problem is potentiated in the 
case of detecting iron content in the liver, since this organ is not only the target organ for 
nanoparticles (>200 nm), but is also the storage organ for iron (the proteins, ferritin and 
hemosiderin). Ferritin is the major form of iron storage with a capacity of about 4500 iron (III) 
ions per protein molecule [11]. 
 One possible way to overcome difficulties in studying the biodistribution of Fe3O4 
nanoparticles is to partially substitute Fe cations with 4f elements, which are not typically found 
in living organisms [12]. This could circumvent the large systematic errors occurring due to the 
inability to distinguish the origin of Fe. From a structural point of view, magnetite crystallizes in 
the cubic spinel type structure, space group (S.G.) Fd3 m. In this structure, cations occupy two 
different non-equivalent crystallographic positions (8b and 24d). Partial Fe cation substitution 
with 4f rare earth (RE) elements in the spinel structure facilitates enhancement or alteration of 
the magnetic properties by changing the chemical composition of the compound. Due to 
appreciable ionic size mismatch between the host and dopant RE, associated structural 
distortions exert considerable crystallite strain [13]. Erbium has a large magnetic moment and 
high magnetic anisotropy, thereby potentially influencing the physical properties of the parent 
compound [13]. One of the concepts behind this study was to prepare magnetite nanoparticles, in 
which a proportion of the iron ions was substituted with erbium.  
Information about the pharmacokinetics and biodistribution patterns of newly designed 
MPNs can be also obtained using a radiotracer technique [14,15]. Distribution of radiolabeled 
MNPs following intravenous administration is determined by measuring radioactivity in tissues 
and/or organs. Given the concerns pertaining to the radioactive character of the probe, limitations 
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are prescribed to minimize animal exposure to radioactivity, while at the same time allowing a 
statistically sufficient number of counts to be collected from the studied specimens. Therefore, 
the radiation doses from the tracer, even when a beta emitting tracer such as 
90
Y is used, neither 
produce any detectable radiation damage nor invoke detectable responses from the studied 
specimens that would alter the results. In addition, the amount of radioactive label, in the 
chemical form given to the animal under study, must not alter the physiological functions of the 
organism.  
 In order to examine the reliability of these methodologies for biodistribution studies, 
(Fe,Er)3O4 citric acid (CA) coated nanoparticles were firstly synthesized and characterized. The 
microstructural properties of the MNPs were studied and their magnetic properties were 
determined. Physicochemical characterization was followed by investigation of cytotoxicity as 
well as embryotoxicity of the MNPs. Through the radiolabeling of prepared samples, several 
important aspects were addressed: i) optimization of the radiolabeling protocol, ii) investigation 
of in vitro and in vivo stability of the radiolabeled MNPs and iii) determination of the 
biodistribution of the radiolabeled MNPs. Finally, for the precise determination of the MNP 
levels in tissues, a parallel approach was used: a combination of radiotracer and ICP methods. 
 
2. Experimental 
2.1. Sample preparation 
Ferrofluids based on CA coated Fe3-xErxO4 nanoparticles, where x=0 and 0.05 (further 
denoted by Er00 and Er05, respectively), were prepared via the modified Massart’s method [16]. 
In a typical synthesis, 1.5 M NaOH was added dropwise to the initial solution with the 
stoichiometric ratio of FeSO4∙7H2O, FeCl3∙6H2O, and Er(NO3)3. After reaching pH 10, the 
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suspension was heated to 80 ºC with vigorous stirring for 30 min. The co-precipitate was 
subjected to magnetic separation and rinsed repeatedly in deionized water to achieve neutral pH. 
CA-coated MNPs were obtained by initiating and conditioning the coating reaction until a stable 
suspension was established. Finally, the MNP suspension was centrifuged and washed several 
times with deionized water to rid it of any excess citric acid.  
 
2.2. Physical characterization 
TGA analyses were performed (30–700 ºC range) on a SDT Q600 TGA/DSC instrument 
(TA Instruments, USA), by utilizing a 20 ºC/min heating rate on less than 10 mg of sample. TGA 
was employed in order to determine the mass contribution of CA in dry MNPs. The CA content 
in Er00 and Er05 MNPs was found to be 18% and 11.5% of the mass, respectively. 
Synchrotron experiments were conducted at 300 K on two samples of Fe3-xErxO4 with 
nominal compositions of x=0 (Er00) and 0.05 (Er05). Experiments were carried out at the X17A 
beam line of the National Synchrotron Light Source (NSLS) at Brookhaven National Laboratory 
(Upton, NY, USA) using a monochromatic x-ray beam with wavelength of 0.1839 Å (E=67.42 
keV). Each sample was loaded into a polyimide capillary (1 mm in diameter) that was mounted 
205.67 mm away from the Perkin Elmer amorphous silicon image plate detector positioned 
perpendicular to the beam path. Data was collected over multiple frames of 60 s each, which 
were further averaged for good statistics. Two-dimensional diffraction patterns were integrated, 
using Fit2D software, into their one-dimensional counterparts. These were corrected for various 
experimental effects, and the corresponding reduced total scattering functions, F(Q), where Q is 
the momentum transfer, were then Sine Fourier transformed into the direct space to obtain the 
atomic pair distribution functions, PDF and G(r). Data reduction was carried out using 
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PDFgetX3 software, with QMAX=24 Å
-1
,which was optimized for minimizing the signal to noise 
ratio and maximizing the r-space resolution.  
Magnetic and TEM measurements were obtained using standard equipment and under 
standard conditions. Magnetic measurements of powder MNPs were performed on a MPMS XL-
5 SQUID magnetometer. Magnetization vs. temperature, M (T), was measured in the temperature 
range 2–300 K under zero-field-cooled (ZFC) and field-cooled (FC) regimes, in 100 Oe. 
Hysteresis loops were measured at 5 K and 300 K in a ZFC regime. Transmission electron 
micrographs and selected-area diffraction patterns were collected with a transmission electron 
microscope (JEM 2100 TEM, Jeol, USA) operating at 200 kV. 
 
2.3. In vitro cell studies: Antiproliferative activity assessed by MTT assay  
Human lung fibroblast (MRC5) and melanoma (A375) cell lines were obtained from the 
ATCC culture collection and maintained and cultured as instructed by ATCC. In order to test 
cytotoxic effects, cells were maintained as monolayers (1x 10
4 
cells well
-1
) and grown in a 
humidified atmosphere of 95% air and 5% CO2 at 37 °C. 
The viability of cells was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction assay [17].This assay was carried out after 48 h of 
cell incubation in appropriate media containing test compounds (Er05 and Fe3O4 naked MNPs) 
at different concentrations and cell viability was measured as described [17]. Prepared 18 nm in 
size naked Fe3O4 MNPs were used as a control for the coated MNPs in toxicity studies. Er05 and 
Fe3O4 solutions in deionized water were filter sterilized (0.2 µm, EMD Millipore, Billerica, 
USA) prior to usage in the cell culture experiments. The results were presented as percentage of 
viability of the control, untreated cells (arbitrarily set to 100%). IC50 values were calculated as 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
8 
 
concentrations at which 50% cell growth inhibition occurred. Experiments were conducted in 
hexaplicate in three independent determinations. Results are presented as means ± SD.  
The morphological appearance of the treated cells was determined using a DM IL LED 
Inverted Microscope (Leica Microsystems, Wetzlar, Germany) under 20×magnification. 
 
2.4. Embryotoxicity studies: Zebrafish (Danio rerio) toxicity assay 
The assessment of toxicity (lethality and teratogenicity) of Er05 MNPs on zebrafish 
embryos was performed following the general rules of the OECD Guidelines for the Testing of 
Chemicals [18]. Adult zebrafish (Danio rerio, wild type) were obtained from a commercial 
supplier (Pet Centar, Belgrade, Serbia) and maintained in fish medium (2 mM CaCl2, 0.5 mM 
MgSO4, 0.7 mM NaHCO3, 0.07 mM KCl) at 27 ± 1°Cunder a 14 h light/10 h dark cycle, and 
regularly fed twice daily with commercially dry flake food supplemented with Artemianauplii 
(TetraMin
TM
 flakes; Tetra Melle, Germany). Collected eggs at the 4- to 16-cellstages were 
individually treated with different concentrations of MNPs (5, 10 or50 μg/ml) after being 
transferred into 96-well plates containing 200 μl of MNP test solution and one egg per well. The 
study was repeated two times using 32 embryos per MPN concentration. Er05 and Fe3O4MNPsin 
deionized water were filter sterilized (0.2 µm, EMD Millipore, Billerica, USA) prior to usage in 
the zebrafish embryo experiments. Apical endpoints (Table S1) were examined and recorded 24, 
48, 72, 96 and 114 h post fertilization (hpf) using an inverted microscope (CKX41; Olympus, 
Tokyo, Japan). 
All studies involving zebrafish were performed in compliance with the European 
directive 86/609/EEC and the ethical guidelines given in the Guide for Care and Use of 
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Laboratory Animals, Institute for Molecular Genetics and Genetic Engineering, University of 
Belgrade. 
 
 
2.5. Radiolabeling of Er05MNPs with 
90
Y and in vitro stability studies 
90
YCl3 was purchased from Polatom, Poland, in a no-carrier-added form (29.64 GBq/cm
3
, 
in 0.05 M HCl, 18.5 TBq/mg Y, according to the product specification). 
90
Y labeling of Er05 MNPs was performed using the method previously applied for the 
radiolabeling of Fe3O4/PEG600diacid MNPs [19].Briefly, 
90
YCl3 solution (5 μl, containing 
approximately 370 MBq) was added to an aqueous suspension of 30 mg/mlEr05 MNPs at pH 6.5. 
The suspension was shaken for 1 h. Radiolabeled Er05 MNPs were then recovered by magnetic 
decantation, the supernatant was removed and the precipitate washed several times with 
deionized water to eliminate any unbound 
90
Y
3+
. The labeling yield was determined as the ratio 
of the measured MNP-associated activity obtained after magnetic separation and the known 
activity used for the radiolabeling. Formation of 
90
Y-labeled Er05 MNPs and radiochemical 
purity were verified by instant thin layer chromatography performed on SG strips (ITLC-SG, 
glass microfiber chromatography paper impregnated with a silica gel) with saline as the mobile 
phase. With this system, 
90
Y-labeled Er05 MNPs remained at the origin (Rf=0.0-0.1), while 
unbound 
90
Y migrated with the solvent front (Rf =0.9-1.0). 
 The bremsstrahlung of 
90
Y radioactivity was measured using a CRC-15 beta radioisotope 
dose calibrator (Capintec, USA) and a NaI (Tl) well-type gamma counter (Wizard 2480, Perkin 
Elmer, USA). All measurements were carried out under the same geometric conditions. The 
results are reported as the mean of at least three measurements ± standard deviation. 
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 The stability of 
90
Y-labeled Er05 MNPs during 72h was determined after magnetic 
precipitation or ITLC-SG with saline as the mobile phase. Amounts (3 mg;0.1 ml) of 
90
Y-labeled 
Er05 MNPs were incubated with 1 ml of either saline or human serum at 37°C. After 3 days of 
incubation, radiolabeled particles were precipitated with a permanent magnet and the activity 
was measured separately in a 0.1 ml aliquot of the supernatant and in the remaining sample 
(radiolabeled MNPs and 0.9 ml supernatant). The radioactivity bound to 
90
Y-labeled Er05 MNPs 
was calculated as follows: the activity of the remainder – the activity of the 0.1 ml supernatant x 
0.9. 
 
2.6. Biodistribution of 
90
Y-labeled Er05 MNPs  
The biodistribution study was performed according to the guidelines of the European 
Council Directive (86/609/EEC) and the Serbian Laboratory Animal Science Association 
(SLASA). Three healthy male 4-week-old Wistar rats (100±10 g body weight, Institute of 
Biology, Vinča Institute of Nuclear Sciences) received 0.1 ml of90Y-labeled Er05MNPs (0.3 mg 
in saline, approx. 2.5 MBq) intravenously (i.v.) injected through the tail vein. The animals were 
sacrificed via spinal cord dislocation at 30 min after injection. Samples of blood and organs of 
interest were excised and weighed, then tissues were homogenized (Bio Spec Products, Inc., 
Bartlesville, USA) and diluted to a final volume of 5 ml with water to reach identical geometry 
and similar probe density. The percentage of injected dose (%ID/g) per gram of organ was 
calculated by comparing the activities with appropriate standards for injected dose (ID). The data 
are presented as average + standard deviation from each group. 
 
2.7. Elemental analysis by ICP-MS 
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Digestion of the samples for ICP measurements was performed on an Advanced 
Microwave Digestion System (ETHOS 1, Milestone, Italy) using a HPR-1000/10S high pressure 
segmented rotor. Pressure-resistant PTFE vessels (volume 100 ml) which were equipped with 
QS-50 Quartz inserts were used. This type of vessel permitted a maximum temperature of 240 ºC 
and a maximum pressure of 100 bar to be applied. Sample digestion was performed as follow: 
whole organs of Wistar rats for biodistribution studies or zebrafish in case of ecotoxicity analysis 
were precisely weighed and mixed in quartz inserts with 5 ml HNO3 (65%, Suprapure®, Merck, 
Germany) and then heated with microwave energy. The temperature was controlled with a 
predetermined power program. Digestion was conducted for 20 min at a constant temperature of 
200 ºC, with a prior warm-up linearly over 10 min to 200 ºC. After total mineralisation and 
cooling to room temperature and without filtration, the solutions were diluted to a fixed volume 
in 10 ml volumetric flasks with ultra-pure water (Barnstead™ GenPure™ Pro, Thermo 
Scientific, Germany) with a conductivity of 0.055 µS/cm. The content of Er in digested sample 
solutions was determined by ICP-MS using an iCAP Qc ICP-MS (Thermo Scientific, Bremen, 
Germany) spectrometer with the operational software Qtegra. For Er determination, the 
spectrometer was adjusted for optimal performance in standard mode using the supplied auto 
tune protocols. The ICP-MS spectrometer was tuned using the solution TUNE B iCAPQ (1 μg/l 
of each: Ba, Bi, Ce, Co, In, Li, U), provided by the manufacturer (Thermo Scientific, Germany). 
Reference standard solutions for spectrometer calibration were prepared on the basis of the 
certified Semi quantitative Standard 1, Specpure® (Alfa Aesar GmbH & Co KG, Germany). Er 
determinations were done measuring two stable naturally occurring erbium isotopes,
166
Er and 
167
Er, and the average valueswere used for further calculations.The limit of quantitation (LOQ) 
for erbium was determined to be 11 ng/l. 
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3. Results and discussion 
3.1. Structure and microstructure analysis 
Analysis of collected synchrotron XRD data showed that Er00 and Er05 crystallized in 
the S.G. Fd 3 m and spinel structure type (Figure 1). Structural modeling of the PDF data was 
carried out using the PDFFIT2program operated under the PDFGui platform using S.G. Fd3 m 
and spinel structure type. Er was assumed to occupy an octahedral 16d position within the spinel 
structure type. The Er content could not be independently verified for the Er-containing materials 
due to inter-parameter correlations within the modeling protocols used, so the Er content was 
considered to be the nominal Er-concentration and octahedral site occupancy. However, the 
presence of Er in the spinel structure was seen through small but observable changes in the 
lattice parameter of the spinel phase, which did not depend on the unit cell content. The lattice 
parameter of the spinel lattice depends on the complex interplay between the size of the ions and 
their distribution. Ionic radii for octahedral (VI) coordination are Fe
3+
(VI) = 0.645 Å, while 
Er
3+
(VI) = 0.89 Å[20].Further verification of the presence of Er on the octahedral spinel sites 
originated from the increased isotropic displacement parameters of octahedral sites and oxygen 
sublattices, which were enlarged for the Er05 sample as compared to the Er00 sample. Final fits 
of PDF data are shown in Figure 2. Small discrepancies between the model and the data in the 
low-r part of the PDF were consistently seen in both materials studied, and are likely attributable 
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to surface effects as well as those of strain related to the finite particle size. Exploring these 
structural effects in greater detail is beyond the scope of this study. 
 
Figure 1. Diffraction patterns obtained in far detector setup (medium-high resolution mode), at 
300 K for Ni standard (top, green profile), Er05 (middle, red profile), and Er00 (bottom, blue 
profile). Sharp Bragg peaks are obtained for the standard, illustrating the measurement 
resolution. Dramatically broader profiles are observed for Er00 and Er05, indicating their 
nanoscale character. 
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Figure 2. Experimental atomic PDFs (open symbols) with converged structural models (solid 
red lines) and associate difference curves (green, offset for clarity) for Ni standard (top), Er05 
(middle), and Er00 (bottom) materials. Data for MNPs were fitted using a spinel Fd-3m model. 
PDF intensity is clearly observable in the of bulk Ni standard data at 50 Angstroms, whereas the 
intensity is clearly washed out for the MNPs studied, indicating loss of structural coherence and 
the nanoscale character of Er00 and Er05. 
 
Structural parameters resulting from the PDF refinements for the principal spinel phase, obtained 
over the 1.5Å-50 Å fitting range, are summarized in Table 1.  
MNP a (Å) Fe-t Uiso (Å
2
) Fe-o Uiso (Å
2
) O Uiso (Å
2
) d (nm) rwp 
Er00 8.355(4) 0.007(2) 0.018(3) 0.022(4) 6.5(7) 0.16 
Er05 8.364(4) 0.008(2) 0.020(3) 0.025(4) 5.3(4) 0.18 
 
Table 1. Structural parameters for the principal spinel (Fd 3 m) phase of the MNPs: lattice 
parameter, a, Isotropic atomic displacement parameter, Uiso, for Fe in tetrahedral (Fe-t) and Fe 
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in octahedral (Fe-o) positions, as well as oxygen. Fits, assuming spherical MNP shape also give 
particle diameter, d in nanometers. Finally, fit residuals rwp give an indication of the goodness of 
fit. 
The microstructure of the MNPs was further examined by TEM analysis. TEM images 
(Figure 3) of both MNP types were analyzed using image processing software, Image J [21]. 
Results of the particle counts are given in the insets. Both histograms resemble log-normal size 
distributions. Average diameters deduced from the count data were 7(2) and 6(1) nm, for Er00 
and Er05, respectively. In comparison with the X-ray analysis, crystallite size was close to the 
size of the particles. This indicated that the materials were indeed MNPs, were comprised of 
single crystallites, and were nearly spherical in shape according to the morphological analysis 
conducted.  
 
Figure 3. TEM images of Er00 (left) and Er05 (right) MNPs. Inset: Particle counts. Scale bar is 10 nm in 
both pictures. 
 
3.2. Magnetic behavior 
Figure 4 shows ZFC-FC curves for both MNP types. Both Er00 and Er05 exhibited 
behavior typical for superparamagnetic samples, with maximum magnetization around 90 K and 
overlapping ZFC and FC curves at higher temperatures. The slight rise of the FC curves with 
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temperature decreases below the maximum points to the presence of interparticle interactions, 
which is expected for powder samples [22]. 
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Figure 4. ZFC-FC curves for Er00 and Er05 MNPs, measured in 100 Oe. 
 
Hysteresis curves for both MNP types at 5 K and 300 K are presented in Figure 5. At 5 K, 
samples had a coercive field around 200 Oe, while it shrank to below 10 Oe at 300 K. Clearly, 
SQUID labels both MNP types as superparamagnetic at 300 K. A weighted Langevin fit was 
employed in order to deduce the magnetization saturation (MS) at 300 K and average size of 
particles. A log-normal particle size distribution, 
          
 
    
 
 
      
   
 
 
 
 
   
     , 
was used. Here, d and σ represent coefficients of the log-normal distribution, and D is the 
diameter of the particle. The complete weighted Langevin function took the form: 
                       
        
  
  
  
  
          
       . 
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Figure 5. Hysteresis of Er00 and Er05 MNPs at 300 K. Lines represent weighted Langevin fits. 
Coercivity values at 5 K can be seen in the inset. 
 
Particles were approximated as spheres with volume V=1/6 πD3. Density ρ was set to 5300 kgm-
3
, which corresponds to the magnetite bulk value, kT represents thermal energy, and B is the 
magnetic flux density. Fitting parameters were d, σ and MS. Expected MNP diameters dLang and 
standard deviations std were calculated using: 
                    and                                     ,(3) 
Final results are presented in Table 2. Derived average diameters showed excellent agreement 
with results of the TEM analysis and values acquired from XRD refinement. 
 
Sample MS
room
(emu/g) dLang (nm) DTEM (nm) DXRD (nm) 
Er00 60.9(2) 7(4) 7(2) 6.5(7) 
Er05 57.3(2) 6(3) 6(1) 5.3(4) 
Table 2. Values of the MS and average diameter from weighted Langevin fit, TEM picture 
analysis and XRD refinement. 
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Binary ferrites (MFe2O4; M=Zn, Mn, Fe, Ni, Cr) and magnetite have often been 
doped/substituted with RE in order to improve their physical properties due to the large 
anisotropy of RE
3+
 moments [23] or structural defects induced by RE ions in the parent 
compound [24]. However, the effects of RE substitution in magnetite and ferrites are still not 
well understood. Our observed MS value was slightly smaller in Er-substituted Fe3O4 MNPs 
(Er05) than in pure Fe3O4 MNPs (Er00)(Table 2). Consequently, from the magnetic point of 
view, the Er05 MNPs are deemed suitable for medical applications.  
 
3.3. Cytotoxicity study 
The cytotoxicity of Er05 MNPs was compared with that of naked Fe3O4MNPsusingtwo 
cell lines. Both MNP types exhibited cytotoxic effects on both cell lines when applied in high 
concentrations (500 μg/ml; data not shown). The IC50 values for Fe3O4 and Er05 MNPs were 
comparable in the case of normal lung fibroblasts, but the selectivity towards the melanoma cell 
line was different (Table 3). Internalization and distribution of the Er05 MNPs was consistently 
good and even throughout the cell lawn (Figure S1). Fe3O4MPNswere 2.5 times more toxic 
towards the melanoma cell line, while Er05 MNPs were 3 times less toxic towards the same cell 
line. This could be due to the specific microenvironment (slight pH differences) that may be 
present in the cancer cell line. 
MNP type MRC5 (lung fibroblasts) A375 (melanoma) 
Naked Fe3O4 50 ± 4 20 ± 2 
Er05 45 ± 6 150 ± 9 
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Table 3. Cytotoxic activity of naked Fe3O4 and Er05 MNPs on human lung fibroblasts and 
melanoma cell line expressed as IC50 values (μg/ml). IC50 values correspond to nanoparticle 
concentrations which inhibited 50% of cell growth during 48 h of treatment (mean ± SD). 
 
3.4. Ecotoxicity study: embryotoxic influence of Er05 MNPs on zebrafish (Danio rerio)  
Zebrafish embryos were used to test the potential toxic effects of Er05 MNPs. Zebrafish 
(Danio rerio) are an excellent in vivo model for physiologically relevant whole-organism and 
behavior-based screening, which cannot be achieved with conventional in vitro systems [25]. 
Zebrafish embryos were developed in suitable medium containing 5 g/ml, 10 g/mlor50 g/ml 
of MNPs, in 3 ml volumes.  
MNP suspensions exerted no toxic effects on zebrafish embryos, even at the highest 
concentration examined (50 g/ml). At this concentration, neither embryo mortality, nor any 
developmental defect, nor hatching delay was detected (Fig. 6). Furthermore, no signs of cardio- 
or neurotoxicity were observed (Fig. 6).  
Nanoparticle aggregation was observed after 72 h incubation at 50 g/ml (Fig. 6), and 
therefore, in order to rule out the possibility that the MPNs had aggregated and did not have the 
chance to exert harmful effect on zebrafish embryogenesis, ICP-MS analysis of treated and 
washed embryos was conducted. Special care was taken to avoid chorion material in the sample 
preparation for the ICP-MS analysis. Uptake of MNPs by zebrafish embryos was studied by both 
ICP-MS techniques. Results are presented in Table 4.  
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Sample Mass of MNPs calculated by 
measuring Er concentration(µg) 
Er05 - zebrafish; (50 µg /ml) 19.51 
Er05 - ISO water; (50 µg /ml) 76.20 
 
Table 4. Results of ICP-MS measurements: masses of MNPs in 1g zebrafish and in 3ml ISO 
water were shown. 
 
The mass of Er05 MPNs in zebrafish was calculated by measuring Er masses using ICP-MS. 
ICP-MS revealed that MNPs were internalized in the embryos treated with them. Consequently, 
it was concluded that the MPNs, which had displayed a slight antiproliferative effect on lung 
fibroblast and melanoma cell lines, were not toxic for zebrafish embryos indicating their 
biosafety and potential application. 
 
Figure 6. Morphology of the zebrafish (Danio rerio) embryos 96 h after treatment with three 
concentrations ofEr05 MNPs. 
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3.5. Radiolabeling of Er05MNPs with 
90
Y and in vitro stability studies 
The radiotracer method, readily and efficiently used in the MNP biodistribution study, firstly 
required optimization of the radiolabeling itself, to ensure that modification of the MNPs did not 
occur, which would have let to misinterpretation of the biodistribution results. 
The highest radiolabeling yield for 
90
Y-labeled Er05 MNPs, achieved under the 
experimental conditions previously described, was 89%, as detected by ITLC-SG and 92% 
determined by magnetic precipitation. Even a small amount of free 
90
Y
3+
 present in the 
suspension could rapidly accumulate in bone, thus giving false results, and therefore, the 
magnetite precipitate was intensely washed several times with deionizied water to remove 
excess, unbound 
90
Y
3+
.  
After 72h of incubation, 
90
Y-labeled Er05 MNPs demonstrated very high stability in 
saline and human serum (94.1 % and 92.7%, respectively),which can be attributed to the strong 
binding of 
90
Y
3+
 by negatively charged carboxylate groups present on the surface of Er05 MNPs. 
At physiological pH, agglomeration of the radiolabeled Er05 MNPs was not observed during 3 
days. Carboxylic groups on the surface of 
90
Y-labeled Er05 MNPs provided significant 
electrostatic repulsion between the nanoparticles, resulting in excellent solubility and stability of 
90
Y-labeled Er05 MNPs in aqueous solution as well as in physiological saline, human serum and 
in vivo. 
 
3.6. Comparative biodistribution study of 
90
Y-labeled Er05 MNPs by radiotracer technique 
and ICP-MS 
The biodistribution of 
90
Y-labeled Er05 MNPs was examined 30 minutes after 
intravenous injection in the animal model, healthy male Wistar rats, by two methods: radiotracer 
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and ICP-MS. Using the radio-tracer method, accumulation of MNPs in organs was quantified by 
measuring the radioactivity of bound radionuclides, while for the ICP-MS method, Er in the 
nanoparticle cores was measured. Radioactivity measurements of dissected tissues showed 
accumulation of 
90
Y-labeled Er05 MNPs mostly in the liver (75.33% ID), followed by lungs 
(16.70% ID) and spleen (2.83% ID), while the remaining 
90
Y-labeled Er05 MNPs were spread 
across the rest of the body (Figure 7).Such distribution is expected because nanoparticles of this 
size rapidly clear from the systemic circulation, predominantly by action of the liver and spleenic 
macrophages [26,27].An insignificant amount of radioactivity (0.44% ID) was detected in femur, 
a target organ for free 
90
Y, indicating that 
90
Y was tightly attached to the MNPs. Lungs, liver, 
spleen and blood were selected for further ICP analysis. Measured concentrations of Er in 
prepared tissue samples were (in µg/organ): lung (49.32), spleen (13.13), liver (264.01) and 
blood (1.07 µg/ml). Results of the radiotracer technique and ICP-MS spectroscopy are presented 
in Figure 8. In order to compare the results of these two methods, the percentages acquired by 
the radiotracer technique for four selected tissues were scaled so that their sum equaled 100%. In 
vivo stability of 
90
Y-labeled Er05 MNPs was proved by in vivo retention of radioactivity in the 
liver, as well as by the constant amount of Er detected over time. This study demonstrates the 
unique advantages of the radiotracer technique: high sensitivity and simplicity. Although the ICP 
method enables detection of trace amount of elements in animal bodies, this measurement 
method suffers from low specificity due to inability to distinguish between endogenous elements 
and MNPs. The ICP-MS method using Er as a tracer proved to be a reliable method for 
quantifying accumulation of radiolabeled MNPs in blood and organs in vivo. Finally, our results 
show very good agreement between these methods and their combined application in our 
biodistribution study of 
90
Y-labeled Er05 MNPs, providing additional credibility to these results. 
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Figure 7. Biodistribution of  
90
Y-labeled Er05 MNPs in rats using the radiotracer technique. 
 
Figure 8. Comparative biodistribution of 
90
Y-labeled Er05 MNPs using the radiotracer 
technique and ICP-MS. Radiotracer technique results for four tissues were scaled to 100% in 
order to compare them with ICP-MS results. 
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4. Conclusion 
The Fe3-xErxO4 (x=0 and 0.05) citric acid coated nanoparticles synthesized using the 
modified Massart’s method displayed high magnetic moments. Cytotoxicity analysis of Er05 
citric acid coated and naked Fe3O4 MNPs indicated that the surface of the MNPs was non-toxic, 
while the toxicological test using zebrafish embryos pointed to the non-toxicity of the cores of 
the MNPs produced. In addition, ICP-MS showed that the MNPs entered the embryos and 
normal embryonal development ensued, so the particles are indeed non-toxic in vivo. The 
combination of the investigated toxicology test and the ICP-MS technique is an effective, fast, 
low cost and reliable method for in vivo toxicological studies.  
 MNPs labeled with radionuclide yttrium, 
90
Y-Er05 MNPs, were obtained in a high 
radiolabeling yield and exhibit high in vitro and in vivo stability. Two complementary 
techniques, radiotracer and ICP-MS, supported each other, showing similar results of uptake in 
different in vivo rat tissues. Combined application of these methods should greatly enhance the 
reliability of studies into the biodistribution of MNPs in in vivo organs and tissues, and could be 
readily used for investigating organ and/or tissue distribution of MNPs potentially delivering a 
range of therapeutics. Additionally, biocompatible Er05 MNPs labeled with 
90
Y are promising 
candidates for combined radionuclide-hyperthermia therapy. 
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Highlights 
 Citric acid coated (Fe,Er)3O4 MNPs were found to induce low toxicity both in human cell 
fibroblasts and in zebrafish (Danio rerio) embryos. 
 
 MNPs labelled with radionuclide yttrium, 90Y-(Fe,Er)3O4  MNPs, were obtained in high 
radiolabelling yield and exhibit high in vitro and in vivo stability. 
 
 90Y-(Fe,Er)3O4  MNPs can be reliably used in bio-distribution studies to obtain accurate 
measurements. 
 
 ICP-MS showed that MNPs do enter embryos, so particles are indeed in vivo non-toxic. 
 
 Combined application of radiotracer and ICP-MS methods greatly enhance the reliability 
of studies into the biodistribution of MNPs in in vivo organs and tissues. 
 
 The combination of the investigated toxicology test and the ICP-MS technique is an 
effective, fast, low cost and reliable method for in vivo toxicological studies.  
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